Alfred Scheidegger
InvestorFounderManaging Partner at Nextech Invest · Board director at Cleave Biosciences
Zurich
Writes $100K – $5M checks · typically $1.5M
FoundedCleave Biosciences
About
Alfred Scheidegger is co-founder and chairman of Lipovectra Inc. He founded and scaled an international venture capital firm and has served as CEO, chairman, and board member across numerous international companies focused on high-growth and innovation sectors including technology, pharma, and biotech. Scheidegger has experience in capital raising, corporate strategy, and operational leadership across Europe, Asia, and the United States, and is fluent in German and English with proficiency in Italian, Japanese, and French.
Board director at Cleave Biosciences
Intro paths
In turn, Alfred can intro founders to Cleave Biosciences's investors below.
Cleave Biosciences's investors · 3
Co-founders at Cleave Biosciences
Experience
- Lipovectra Inc.Co-Founder, Chairman of the Board of Directorcurrent2025 — present
- BioNeex UGMember of the Advisory Boardcurrent2024 — present
- KeliomicsAdvisor2024 — 2026Портленд, OR
- Wemedoo AGChairman of the Board of Directors2023 — 2026
- Nextech Invest Ltd.Founder, Managing Partner, Member of the Board of Directors1998 — 2025Zurich, Switzerland
- Dottikon Exclusive Synthesis AGVice Chairman of the Board of Directors2011 — 2024Dottikon, Switzerland
- Kura Kura International Ltd.Senior Advisor2021 — 2022Singapore
- Rising Tide Foundation GroupMember of the Foundation Board2017 — 2021Schaffhausen, Switzerland
- Cleave Biosciences, Inc.Member of the Board Of Directors2016 — 2019Burlingame, USA
- MolecularMDObserver of the Board of Directors2012 — 2016Portland, OR, USA
- Palyon Medical CorporationMember of the Board of Directors2009 — 2015Санта-Моника, CA
- TRACON PharmaceuticalsMember of the Board of Directors2012 — 2015San Diego, CA, USA
- Tetralogic PharmaceuticalsObserver of the Board of Directors2012 — 2013Malvern, PA, USA
- MacroGenics, Inc.Observer of the Board of Directors2012 — 2013Rockville, MD, USA
- The Genetics CompanyChairman of the Board of Directors2003 — 2013Zürich, Schweiz
- ImVisioN Therapeutics Inc.Observer of the Board of Directors2008 — 2012Muttenz, Basel-Landschaft, Schweiz
- Ganymed Pharmaceuticals AGMember of the Board of Directors2006 — 2008Mainz, Germany
- Agensys, Inc.Observer of the Board of Directors2007Santa Monica, CA, USA
- >>venture>> | Companies for tomorrowCo-Founder, Member of the Project Team, Member of the Jury1997 — 2007Zurich, Switzerland
- BioVision AGMember of the Supervisory Board2003 — 2005Hannover, Niedersachsen, Deutschland
Education
- Harvard Business SchoolThe General Manager, Business Administration and Management1989
- Kyoto UniversityPostdoc in Enzymology1985 — 1987
- Biozentrum, University of BaselDoctor of Philosophy (PhD), Biochemistry and Microbiology1981 — 1984
- University of BaselDiploma in Microbiology1976 — 1980
Skills & more
+12 more
Due DiligenceMedical DevicesGrowth CapitalBusiness StrategyStrategyValuationVenture FinancingPharmaceutical IndustryRisikokapitalPharmaindustriePrivates EigenkapitalFusionen und ÜbernahmenLanguages English · French · German · Italian · Japanese
From Alfred's professional profile.
Deals · 1
Cleave BiosciencesBoard seat
via Nextech Invest · filed Aug 2016 · $36.8M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Nextech Invest
Frequently asked questions
- Where does Alfred Scheidegger work?
- Alfred Scheidegger is Managing Partner at Nextech Invest and Founder at Cleave Biosciences.
- What check size does Alfred Scheidegger write?
- Alfred Scheidegger typically writes checks of $100K – $5M.
- What companies did Alfred Scheidegger found?
- Alfred Scheidegger founded Cleave Biosciences.
Same school
Also attended Harvard Business School1,971
+ 1,965 more
Also attended Kyoto University21
+ 15 more
Also attended Biozentrum, University of Basel2
Also attended University of Basel17
+ 11 more
































